First Waterless Nasal Allergy Spray Approved for Children as Young as Four Years of Age JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (TEVJF), (NYSE:TEVA) announced today that the U ...
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced positive findings from a Phase III clinical study that examined the safety and efficacy of QNASL® ...
Teva announced that the Food and Drug Administration (FDA) has approved QNASL (beclomethasone dipropionate) 40mcg for the treatment of nasal symptoms associated with allergic rhinitis in children 4–11 ...
Beclomethasone dipropionate (aka beclometasone) is a venerable steroidal drug with a variety of uses. It was first described in a 1964 Belgian patent to the Glaxo Group (Greenford, UK; now part of GSK ...
Children may be at risk of receiving rhinitis treatment that suppresses growth – but the problem can be avoided through careful selection of treatment. This was the overwhelming message emerging from ...
Objective: The aim of this study was to demonstrate that a new non-extra-fine metered-dose inhaler formulation of beclomethasone (beclomethasone dipropionate) containing hydrofluoroalkane (HFA) ...
JERUSALEM — The Food and Drug Administration has accepted an approval application for a drug made by Teva Pharmaceutical Industries for treating allergies, Teva said. The Israeli drug maker said the ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/l62c4c/inhalation_and) has announced the addition of the "Inhalation & Nasal ...
July 8, 2005 — A short course of systemic corticosteroid plus local vasoconstrictor therapy followed by long-term use of a topical corticosteroid is an effective approach for the management of nasal ...
Health Education Quarterly, Vol. 14, No. 3 (Fall 1987), pp. 309-317 (9 pages) The purpose of the study was to evaluate the efficacy of a structured education program on knowledge and psychomotor ...
First and Only Breath-Actuated Aerosol Inhaled Corticosteroid in the United States Designed to Help Eliminate the Need for Hand-Breath Coordination JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results